Zelira Therapeutics Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter (OTC) products, including SprinJeneCBD, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is based in Perth, Australia.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
0.70
Market cap
$7.38M
Enterprise value
$10.04M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://zeliratx.com |
| Mailing address | 101 St Georges Terrace Level 3 Perth WA 6000 Australia |
| Phone / Fax | 61 8 6558 0886 / 61 8 6316 3337 |
Dividends
More: Zelira Therapeutics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Zelira Therapeutics paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ZLD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Zelira Therapeutics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Osagie O. Imasogie Esq. | Founder & Chairman | 63 | |
| Dr. Oludare Odumosu | MD, Global CEO & Director | ||
| Mr. Greg Blake | Executive Director | ||
| Mr. Timothy Ryan Slate | Company Secretary & Non-Executive Director | ||
| Mr. Rahul Ganesan | Vice President of Finance & Accounting | ||
| Dr. Patty Washer | Clinical Trial Consultant |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-658713.13%
Return on assets
-83.30%
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Zelira Therapeutics is 7.38M and its enterprise value is 10.04M. The enterprise value to revenue ratio of ZLD is 15303.41. The enterprise value to EBITDA ratio of ZLD is -2.40.
The ZLD's stocks Beta value is 0.70 making it 30% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Zelira Therapeutics (ZLD)
Zelira Therapeutics (ASX:ZLD) Frequently Asked Questions
1. What is Zelira Therapeutics's Stock Symbol?
Zelira Therapeutics trades on ASX under the ticker symbol "ZLD".
2. What is Zelira Therapeutics's stock price today?
One share of ZLD stock can currently be purchased for approximately $0.62.
3. How can I contact Zelira Therapeutics?
Zelira Therapeutics's mailing address is 101 St Georges Terrace Level 3 Perth WA 6000 Australia. The company can be reached via phone at 61 8 6558 0886.
4. What is Zelira Therapeutics's official website?
The official website of Zelira Therapeutics is https://zeliratx.com.